Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Form
Filing Date
May 17, 2021
Document Date
Apr 19, 2021
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
NICHOLS DAVID WAYNE